Intranasal Scopolamine for Motion Sickness

Volume: 90, Issue: 11, Pages: 917 - 924
Published: Nov 1, 2019
Abstract
INTRODUCTION: Rapid onset, noninjection methods are required to provide “as needed” therapy for motion sickness. Intranasal scopolamine (IN SCOP) is attractive because it can be fast acting and work when gastric motility is slowed. Intranasal administration can provide a time to maximal concentration (T max ) of drugs (e.g., naloxone and midazolam) of 30 min or less. We evaluated the efficacy, pharmacodynamics, and pharmacokinetics of IN SCOP in...
Paper Details
Title
Intranasal Scopolamine for Motion Sickness
Published Date
Nov 1, 2019
Volume
90
Issue
11
Pages
917 - 924
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.